Grace Therapeutics's total assets for Q3 2026 were C$68.49M, an increase of 2.87% from the previous quarter. GRCE total liabilities were C$3.60M for the fiscal quarter, a -4.31% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.